Olmesartan/amlodipine

DRUG2 trials

Sponsors

Monash University, Institut für Pharmakologie und Präventive Medizin

Conditions

Hypertension

Phase 4

Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure Study

WithdrawnNCT01089452

Monash UniversityHypertension

Updated: 2015-06-03

Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mg

CompletedNCT01611077

Institut für Pharmakologie und Präventive MedizinHypertension

Start: 2012-01-31End: 2013-01-31Updated: 2017-02-23